share_log

美迪西(688202.SH):已与多家AI制药企业达成战略合作

Medici (688202.SH): Has reached strategic cooperation with many AI pharmaceutical companies

Gelonghui Finance ·  Mar 15 07:54

Gelonghui, March 15 | Medici (688202.SH) said on the investor interactive platform that the company will respond positively to changes in the industry and market environment, continue to cultivate its main business, continue to optimize operations, increase domestic and foreign market expansion efforts, improve the efficiency of project implementation and project delivery, and ensure orderly operation. The company will continue to consolidate pre-clinical integrated comprehensive R&D service capabilities, and while expanding its business scale, actively promote various measures to improve quality and efficiency to improve operational efficiency and profitability. The company has always paid close attention to the development trend of AI technology, and has reached strategic cooperation with many AI pharmaceutical companies to fully integrate external technical resources and internal R&D capabilities to achieve two-way empowerment. The company will continue to actively explore the application of related technologies in R&D business in conjunction with its own business.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment